Subscribe to PLMJ’s newsletters to receive the most up-to-date legal insights and our invitations to exclusive events.
We are looking for people who aim to go further and face the future with confidence.
Subscribe to PLMJ’s newsletters to receive the most up-to-date legal insights and our invitations to exclusive events.
We are looking for people who aim to go further and face the future with confidence.
PLMJ advised Biorce on a €44 million investment round.
This was the largest Series A round for an Iberian health tech start-up, led by DST Global with participation from Norrsken, YZR, Mustard Seed Maze (MSM) and several leading angel investors.
The transaction was led by Alexander Ehlert, a partner in the Corporate M&A practice at PLMJ. In his team were Leonor Melo Bento, Beatriz Veiga Santos and Alice Correia Pires, who are also lawyers in the same practice.
The investment will finance Biorce's international expansion and reinforce the company's ambition to lead the transformation of clinical trials through AI.
The start-up also plans to increase its team by up to 250 people by the end of the year and prepare to open a new office in Barcelona.